Genmab A (GMAB) Net Shares Issued and Repurchased (2023 - 2026)

Genmab A's Net Shares Issued and Repurchased history runs 4 years deep, the most recent figure standing at -$96.0 million for Q1 2026.

• Quarterly Net Shares Issued and Repurchased changed N/A year-over-year to -$96.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 billion (changed N/A YoY) and the FY2022 annual result came in at -$128.0 million, changed N/A from the prior year.
• Net Shares Issued and Repurchased was -$96.0 million for Q1 2026 at Genmab A, up from -$430.0 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at -$79.0 million in Q1 2024 and bottomed at -$560.0 million in Q3 2024.
• A 4-year average of -$341.1 million and a median of -$418.0 million in 2025 frame the typical range for Net Shares Issued and Repurchased.
• Annual changes were most pronounced in 2024 — Net Shares Issued and Repurchased slumped 591.36% — and 2025, when it grew 23.21%.
• Genmab A's Net Shares Issued and Repurchased stood at -$81.0 million in 2023, then slumped by 591.36% to -$560.0 million in 2024, then gained by 23.21% to -$430.0 million in 2025, then jumped by 77.67% to -$96.0 million in 2026.
• Business Quant data shows GMAB's Net Shares Issued and Repurchased at -$96.0 million in Q1 2026, -$430.0 million in Q3 2025, and -$406.0 million in Q2 2025.